Table 4.

Treatment of patients with STAT1 LOF mutations.

Treatment	Patients
Antimycobacterial treatment	n = 18
Isoniazide	n = 11
Rifampicin	n = 17
Ethambutol	n = 12
Pyrazinamide	n = 1
Amikacin	n = 2
Fluoroquinolones	n = 6
Linezolid	n = 2
Antibiotic prophylaxis	n = 4
Co-trimoxazole	n = 2
Macrolides	n = 2
Antiviral prophylaxis	n = 5
Polyvalent immunoglobulins	n = 2
Immunotherapy	n = 8
IFN	n = 6
Infliximab	n = 1
Rituximab	n = 1
Immunosuppressive therapies	n = 4
Hematopoietic stem cell transplantation (HSCT)	n = 3